|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The maker of scientific instruments hiked full-year expectations in light of its $1.3 billion deal for Affymetrix.
Thermo Fisher Scientific Inc reported a higher first-quarter revenue and profit, helped by strength in its life sciences unit and the world's largest maker of scientific instruments also raised its full-year forecast. The company raised its forecast to include the impact of the weakening dollar and the results of Affymetrix, which it bought last month. Thermo Fisher staved off a competing bid for Affymetrix from Origin Technologies Corp, owned by Affymetrix's former employees.
On January 8, 2016, Thermo Fisher Scientific (TMO) announced the acquisition of Affymetrix for approximately $1.3 billion.